feed,title,long_url,short_url
Investors,Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug,https://www.investors.com/news/technology/biogen-stock-alzheimers-treatment-leqembi-europe/,https://da.gd/k4IlV
